GDF15 and metabolic dysfunction-associated steatotic liver disease: The IVW approach demonstrated a causal correlation between elevated circulating GDF-15 levels and a higher risk of NAFLD (OR = 1.16; 95% CI = 1.03–1.30; p=0.017) in the primary analysis.